"In 1970, the U.S. government rescheduled psychedelics as Schedule 1 drugs, ultimately ending scientific research on psychedelics." 

"It is not known whether psilocybin is addictive. There are no FDA-approved medications to treat addiction to psilocybin or other hallucinogens."

"The lethal dose from psilocybin toxicity alone is unknown at recreational or medicinal levels, and has rarely been documented—as of 2011, only two cases attributed to overdosing on hallucinogenic mushrooms (without concurrent use of other drugs) have been reported in the scientific literature and may involve other factors aside from psilocybin."

"Psilocybin mushrooms lack the same addictive potential of more common drugs of abuse (e.g., opioids, stimulants). Studies show that people who use mushrooms regularly do not follow typical patterns of addiction..."

"South American Aztec Indians referred to them as teonanacatl, meaning "god's flesh," and they were used in religious and healing rituals." "6,000-year-old pictographs discovered near the Spanish town of Villar del Humo illustrate several mushrooms that have been tentatively identified as Psilocybe hispanica, a hallucinogenic species native to the area."

"Psilocybin is present in varying concentrations in over 200 species of Basidiomycota mushrooms."
"Fungi are among the most diverse groups of organisms on Earth, with a global diversity estimated at 0.8 million to 5.1 million species."

"Psilocybin mushrooms have low toxicity, and death from an overdose is very rare. One survey in 2016 found that out of more than 12,000 users who took psilocybin, only 0.2% reported emergency medical treatment. That rate is 5 times lower than MDMA (Ecstasy), LSD, and cocaine."

The Therapeutic Potential of Psilocybin - PMC - NCBI

Psilocybin (Mushrooms) | Health Promotion - Brown University

Psychedelics Research and Psilocybin Therapy

Psilocybin - Psychedelic Science Review

Psilocybin | The Beckley Foundation The Beckley Foundation

“Magic Mushrooms,” Psilocybin and Mental Health

Psilocybin targets a common molecular mechanism for cognitive impairment

Psilocybin Therapeutic Research: The Present and Future

THE CANCER-FIGHTING POTENTIAL OF AGARICUS BISPORUS

Homebrewed psilocybin: can new routes for pharmaceutical

Texas the Latest State to Legalize Psychedelic Medical

Psilocybin and the TRIP Program at Pacific Neuroscience

Psilocybin-Enhanced Psychotherapy for Methamphetamine

'Magic Mushrooms' Can Help Smokers Break the Habit

Psilocybin Found to Rapidly Improve Depressive Symptoms

Muscaria and psilocybin-containing mushrooms in Christian art​

Psychedelics, Sociality, and Human Evolution - PMC - NCBI

psilocin | Effects, Mushrooms, & Regulation | Britannica

Fungi from the Biblical Perspective​

Infamous Patent on Synthetic Psilocybin

US10519175B2 Preparation of psilocybin

Psilocybin Patent Tracker​

All You Tube Videos Below Line
__________________________________________________________________________

The Battle Over Psychedelic Therapy’s Future

Psychedelics: The scientific renaissance of mind-altering drugs

The science of psilocybin and its use to relieve suffering

Psychedelics Are Fueling a Mental Health Revolution

Paul Stamets – Psilocybin Mushroom Medicines

The Remarkable Results of Microdosing: James Fadiman

Your Brain on Psilocybin

Psilocybin may ‘reset’ the brain to help manage treatment-resistant depression

How Magic Mushrooms Affect Your Brain

Magic Mushrooms DEMYSTIFIED: The Science and Practice Explained

Microdosing Psychedelics

From Spores To Mycelium To Mushroom And Back Again!​

**Psilocybin**
* Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, known as psilocybin mushrooms or "magic mushrooms".
* Psilocybin has been used in religious and healing rituals for thousands of years, and has been shown to have therapeutic potential in treating various mental health conditions.

**History**
* Psilocybin was first isolated in the 1950s and was initially used in psychotherapy.
* In 1970, the U.S. government rescheduled psychedelics as Schedule 1 drugs, effectively ending scientific research on psilocybin.
* In recent years, there has been a renewed interest in the therapeutic potential of psilocybin, and it has been studied in various clinical trials.

**Safety**
* Psilocybin has low toxicity and death from an overdose is very rare.
* One survey found that only 0.2% of users reported emergency medical treatment after taking psilocybin.
* Psilocybin is not known to be addictive, and studies have shown that people who use it regularly do not exhibit typical patterns of addiction.

**Therapeutic Potential**
* Psilocybin has been shown to have therapeutic potential in treating various mental health conditions, including depression, anxiety, and addiction.
* It has been used in clinical trials to treat treatment-resistant depression, and has been shown to rapidly improve depressive symptoms.
* Psilocybin has also been used to help smokers quit smoking and to reduce symptoms of post-traumatic stress disorder (PTSD).

**Mechanism of Action**
* Psilocybin is believed to work by altering the activity of serotonin receptors in the brain, which can lead to changes in mood and perception.
* It has also been shown to target a common molecular mechanism for cognitive impairment.

**Research**
* There is ongoing research into the therapeutic potential of psilocybin, and it has been studied in various clinical trials.
* The Beckley Foundation has been a leading advocate for psilocybin research and has funded several studies on its potential therapeutic uses.

**Legal Status**
* Psilocybin is currently illegal in most countries, including the United States, where it is classified as a Schedule 1 drug.
* However, there are efforts underway to change the legal status of psilocybin and to make it available for therapeutic use.

**Future Directions**
* The future of psilocybin mushrooms is brimming with promise, poised at the intersection of ancient wisdom and modern science. Despite facing regulatory challenges and a hiatus in research during the 1970s, psilocybin's therapeutic potential has resurfaced as a beacon of hope in the treatment of various mental health conditions. With its low toxicity and rare instances of overdose, psilocybin offers a safer alternative to conventional treatments for depression, anxiety, addiction, and PTSD. As ongoing research sheds light on its mechanisms of action and therapeutic efficacy, there's growing momentum behind efforts to reconsider its legal status and explore its potential in clinical settings. The future of psilocybin research holds the promise of transformative breakthroughs in mental health care, offering renewed hope for those in need of healing and relief.

Biblical Expert Explains MANNA In The Bible A.K.A. Magic Mushrooms Or Another Form Of

The Spirit Of Amanita Muscaria